Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumors of the nervous and endocrine systems in children

Cancer and Metastasis Reviews

Volumn 27, Issue 4, 2008, Pages 665-677

  O'Dorisio, M Sue ^a   Khanna, Geetika ^a   Bushnell, David ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

CT; Diagnostic imaging; Medulloblastoma; MRI; Neuroblastoma; Neuroendocrine tumors; Pediatric; PET; SPECT; Surveillance imaging

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 131; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID 3 TYROSINE OCTREOTIDE Y 90; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID TYROSINE 3 OCTREOTIDE GA 68; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID TYROSINE 3 OCTREOTIDE Y 86; ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; FLUORODOPA F 18; FLUOROTHYMIDINE F 18; METAIODOBENZYLGUANIDINE I 124; OCTREOTATE LU 177; OCTREOTIDE; OCTREOTIDE GA 68; ONALTA; PENTETIC ACID OCTREOTIDE IN 111; PENTETREOTIDE; SOMATOSTATIN DERIVATIVE; TRACER; UNCLASSIFIED DRUG;

ABDOMEN; APPENDIX TUMOR; BONE METASTASIS; BRAIN TUMOR; BRONCHUS CARCINOID; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CARCINOID; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DOSIMETRY; ENDOCRINE TUMOR; GASTRINOMA; HODGKIN DISEASE; HUMAN; ILEUM CANCER; IMAGING; LIVER METASTASIS; MEDULLOBLASTOMA; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; NEUROENDOCRINE TUMOR; NONHUMAN; PANCREAS ISLET CELL TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX; TREATMENT RESPONSE; TUMOR DIAGNOSIS;

3-IODOBENZYLGUANIDINE; CHILD; DIAGNOSTIC IMAGING; ENDOCRINE GLAND NEOPLASMS; HUMANS; NEOPLASMS, GERM CELL AND EMBRYONAL; NERVOUS SYSTEM NEOPLASMS; OCTREOTIDE; RADIOPHARMACEUTICALS;

EID: 52549088077     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-008-9153-8     Document Type: Review

References (63)

1. Heideman, R. L., Packer, R. J., Albright, L. A., Freeman, C. R., & Rorke, L. B. (1997). In P. A. Pizzo, & D. G. Poplack (Eds.), Principles and practice of pediatric oncology pp. 633-697. Philadelphia: Lippincott-Raven.
2. K. Hirakawa K. Suzuki S. Ueda J. Handa 1986 Fetal origin of the medulloblastoma: Evidence from growth analysis of two cases Acta Neuropathologica (Berl) 70 3-4 227 234
3. A. T. Yachnis L. B. Rorke J. Q. Trojanowski 1994 Cerebellar dysplasias in humans: Development and possible relationship to glial and primitive neuroectodermal tumors of the cerebellar vermis Journal of Neuropathology and Experimental Neurology 53 1 61 71
4. E. Scherini G. Bernocchi 1994 CisDDP treatment and development of the rat cerebellum Progress in Neurobiology 42 2 161 196
5. L. Zhang J. E. Goldman 1996 Generation of cerebellar interneurons from dividing progenitors in white matter Neuron 16 1 47 54
6. L. J. Rubinstein 1985 Embryonal central neuroepithelial tumors and their differentiating potential. A cytogenetic view of a complex neuro-oncological problem Journal of Neurosurgery 62 6 795 805
7. P. Bailey H. Cushing 1925 Medulloblastoma cerebelli: A common type of midcerebellar glioma of childhood Archives of Neurology and Psychiatry 14 192 224
8. J. Q. Trojanowski T. Tohyama V. M. Lee 1992 Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts Molecular and Chemical Neuropathology 17 2 121 135
9. R. J. Packer 1999 Childhood medulloblastoma: Progress and future challenges Brain & Development 21 2 75 81
10. J. G. Gurney N. S. Kadan-Lottick R. J. Packer J. P. Neglia C. A. Sklar J. A. Punyko 2003 Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study Cancer 97 3 663 673
11. Fangusaro, J., Finlay, J., Sposto, R., Ji, L., Saly, M., Zacharoulis, S., et al. (2007). Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the Head Start I and II experience. Pediatr Blood Cancer.
12. K. S. Bull H. A. Spoudeas G. Yadegarfar C. R. Kennedy 2007 Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: A follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG) Journal of Clinical Oncology 25 27 4239 4245
13. W. R. Polkinghorn N. J. Tarbell 2007 Medulloblastoma: Tumorigenesis, current clinical paradigm, and efforts to improve risk stratification Nat Clin Pract Oncol 4 5 295 304
14. M. Dennis B. J. Spiegler C. R. Hetherington M. L. Greenberg 1996 Neuropsychological sequelae of the treatment of children with medulloblastoma Journal of Neuro-oncology 29 1 91 101
15. E. Hoppe-Hirsch L. Brunet F. Laroussinie G. Cinalli A. Pierre-Kahn D. Renier 1995 Intellectual outcome in children with malignant tumors of the posterior fossa: Influence of the field of irradiation and quality of surgery Child's Nervous System 11 6 340 345
16. K. M. David A. T. Casey R. D. Hayward W. F. Harkness K. Phipps A. M. Wade 1997 Medulloblastoma: Is the 5-year survival rate improving? A review of 80 cases from a single institution Journal of Neurosurgery 86 1 13 21
17. G. Khanna M. S. O'Dorisio Y. Menda C. Glasier B. Deyoung B. J. Smith 2007 Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies Pediatric Blood and Cancer 50 561 566
18. J. A. Biegel 1997 Genetics of pediatric central nervous system tumors Journal of Pediatric Hematology Oncology 19 6 492 501
19. K. K. Wilgenbus P. Seranski A. Brown B. Leuchs A. Mincheva P. Lichter 1997 Molecular characterization of a genetically unstable region containing the SMS critical area and a breakpoint cluster for human PNETs Genomics 42 1 1 10
20. S. H. Bigner E. Schrock 1997 Molecular cytogenetics of brain tumors Journal of Neuropathology and Experimental Neurology 56 11 1173 1181
21. D. N. MacGregor E. B. Ziff 1990 Elevated c-myc expression in childhood medulloblastomas Pediatric Research 28 1 63 68 Ref Type: Abstract
22. M. C. Fruhwald M. S. O'Dorisio L. J. Rush J. L. Reiter D. J. Smiraglia G. Wenger 2000 Gene amplification in PNETs/medulloblastomas: Mapping of a novel amplified gene within the MYCN amplicon Journal of Medical Genetics 37 7 501 509
23. L. V. Goodrich L. Milenkovic K. M. Higgins M. P. Scott 1997 Altered neural cell fates and medulloblastoma in mouse patched mutants Science 277 5329 1109 1113
24. T. Pietsch A. Waha A. Koch J. Kraus S. Albrecht J. Tonn 1997 Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched Cancer Research 57 11 2085 2088
25. M. Zakrzewska P. Rieske M. biec-Rychter K. Zakrzewski L. Polis T. Fiks 2004 Molecular abnormalities in pediatric embryonal brain tumors-analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22 Clinical Neuropathology 23 5 209 217
26. M. Wolter J. Reifenberger C. Sommer T. Ruzicka G. Reifenberger 1997 Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system Cancer Research 57 13 2581 2585
27. T. Uziel F. Zindy S. Xie Y. Lee A. Forget S. Magdaleno 2005 The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation Genes & Development 19 22 2656 2667
28. F. Zindy T. Uziel O. Ayrault C. Calabrese M. Valentine J. E. Rehg 2007 Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors Cancer Research 67 6 2676 2684
29. J. Muhlisch T. Bajanowski C. H. Rickert W. Roggendorf G. Wurthwein H. Jurgens 2007 Frequent but borderline methylation of p16 (INK4a) and TIMP3 in medulloblastoma and sPNET revealed by quantitative analyses Journal of Neuro-oncology 83 1 17 29
30. I. Sardi D. Cavalieri M. Massimino 2007 Emerging treatments and gene expression profiling in high-risk medulloblastoma Paediatric Drugs 9 2 81 96
31. Brodeur, G. M., & Maris, J. M. (2001). In P. A. Pizzo, & D. G. Poplack (Eds.), Principles and practice of pediatric oncology pp. 895-937. Philadelphia: Lippincott Williams & Wilkins.
32. C. J. Thiele 1991 Biology of pediatric peripheral neuroectodermal tumors Cancer Metastasis Reviews 10 4 311 319
33. L. P. Dehner 1993 Primitive neuroectodermal tumor and Ewing's sarcoma American Journal of Surgical Pathology 17 1 1 13
34. J. Kitlinska K. Abe L. Kuo J. Pons M. Yu L. Li 2005 Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors Cancer Research 65 5 1719 1728
35. K. K. Matthay J. G. Villablanca R. C. Seeger D. O. Stram R. E. Harris N. K. Ramsay 1999 Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group New England Journal of Medicine 341 16 1165 1173
36. O. Altungoz N. Aygun S. Tumer E. Ozer N. Olgun M. Sakizli 2007 Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma Cancer Genetics and Cytogenetics 172 2 113 119
37. M. N. Gurcan T. Pan H. Shimada J. Saltz 2006 Image analysis for neuroblastoma classification: Segmentation of cell nuclei Conference Proceedings of IEEE Engineering in Medicine and Biology Society 1 4844 4847
38. G. M. Brodeur R. C. Seeger M. Schwab H. E. Varmus J. M. Bishop 1984 Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage Science 224 4653 1121 1124
39. H. Sano J. Bonadio R. B. Gerbing W. B. London K. K. Matthay J. N. Lukens 2006 International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age European Journal of Cancer 42 8 1113 1119
40. I. M. Modlin M. Kidd I. Latich M. N. Zikusoka G. N. Eick S. M. Mane 2006 Genetic differentiation of appendiceal tumor malignancy: A guide for the perplexed Annals of Surgery 244 1 52 60
41. B. Stinner M. Rothmund 2005 Neuroendocrine tumours (carcinoids) of the appendix Best Pract Res Clin Gastroenterol 19 5 729 738
42. G. Khanna M. S. O'Dorisio Y. Menda P. Kirby S. Kao Y. Sato 2007 Gastroenteropancreatic Neuroendocrine Tumors in Children and Young Adults Pediatric Radiology 38 251 259
43. SEER Cancer Statistics Review, 1973-2004. 1-11-2006. Ref Type: Report
44. A. I. Vinik N. Thompson F. Eckhauser A. R. Moattari 1989 Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management Acta Oncologica 28 3 389 402
45. S. W. Lamberts G. F. Pieters H. J. Metselaar G. L. Ong H. S. Tan J. C. Reubi 1988 Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours Acta Endocrinologica (Copenh) 119 4 561 566
46. E. W. McDermott B. Guduric M. F. Brennan 1994 Prognostic variables in patients with gastrointestinal carcinoid tumours British Journal of Surgery 81 7 1007 1009
47. R. R. Broaddus C. E. Herzog M. J. Hicks 2003 Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence Archives of Pathology and Laboratory Medicine 127 9 1200 1203
48. F. D. Pashankar M. S. O'Dorisio Y. Menda 2005 MIBG and somatostatin receptor analogs in children: Current concepts on diagnostic and therapeutic use Journal of Nuclear Medicine 46 Suppl 1 55S 61S
49. Kloppel G PAHP 2004 The gastroenteropancreatic neuroendocrine cell system and its tumors: The WHO classification Annals of the New York Academy of Sciences 1014 13 27
50. G. Rindi G. Kloppel H. Alhman M. Caplin A. Couvelard W. W. de Herder 2006 TNM staging of foregut (neuro)endocrine tumors: A consensus proposal including a grading system Virchows Archives 449 4 395 401
51. I. M. Modlin K. D. Lye M. Kidd 2003 A 5-decade analysis of 13,715 carcinoid tumors Cancer 97 4 934 959
52. M. Bonato M. Cerati A. Pagani M. Papotti F. Bosi G. Bussolati 1992 Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases Virchows Archiv. A, Pathological Anatomy and Histopathology 420 3 201 211
53. I. M. Modlin M. Kidd R. Pfragner G. N. Eick M. C. Champaneria 2006 The functional characterization of normal and neoplastic human enterochromaffin cells Journal of Clinical Endocrinology and Metabolism 91 6 2340 2348
54. M. H. Kulke R. J. Mayer 1999 Carcinoid tumors New England Journal of Medicine 340 11 858 868
55. G. Rindi C. Capella C. Bordi E. Solcia 2002 Guidelines and minimal diagnostic criteria for the histological diagnosis of endocrine tumors of the gastroenteropancreatic type Pathologica 94 3 142 147
56. R. Fiocca G. Rindi C. Capella L. Grimelius J. M. Polak T. W. Schwartz 1987 Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells Regulatory Peptide 17 1 9 29
57. L. K. Shankar J. M. Hoffman S. Bacharach M. M. Graham J. Karp A. A. Lammertsma 2006 Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials Journal of Nuclear Medicine 47 6 1059 1066
58. R. J. Ott D. Tait M. A. Flower J. W. Babich R. M. Lambrecht 1992 Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography British Journal of Radiology 65 777 787 791
59. H. R. Maecke M. Hofmann U. Haberkorn 2005 (68)Ga-labeled peptides in tumor imaging Journal of Nuclear Medicine 46 Suppl 1 172S 178S
60. V. Nataf M. Balard V. de B K. Kerrou F. Gutman D. Grahek 2006 Safety of 18F-DOPA Injection for PET of Carcinoid Tumor Journal of Nuclear Medicine 47 10 1732
61. M. E. Juweid G. A. Wiseman J. M. Vose J. M. Ritchie Y. Menda J. E. Wooldridge 2005 Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography Journal of Clinical Oncology 23 21 4652 4661
62. J. P. Howard J. M. Maris L. S. Kersun J. P. Huberty S. C. Cheng R. A. Hawkins 2005 Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma Pediatric Blood and Cancer 44 3 232 239
63. B. Rose K. K. Matthay D. Price J. Huberty B. Klencke J. A. Norton 2003 High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma Cancer 98 2 239 248